LRRK2 and Parkinson disease: Our findings confirm the prominent role of variants in LRRK2 and GBA1 on increased PD risk, in particular the pathogenic variants: LRRK2 p.G2019S and GBA1 p.N409S, p.T408M, and p.E365K.